Cargando…

Assessing Susceptibility to Age-related Macular Degeneration with Proteomic and Genomic Biomarkers

Age-related macular degeneration (AMD) is a progressive disease and major cause of severe visual loss. Toward the discovery of tools for early identification of AMD susceptibility, we evaluated the combined predictive capability of proteomic and genomic AMD biomarkers. We quantified plasma carboxyet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Jiayin, Pauer, Gayle J. T., Yue, Xiuzhen, Narendra, Umadevi, Sturgill, Gwen M., Bena, James, Gu, Xiaorong, Peachey, Neal S., Salomon, Robert G., Hagstrom, Stephanie A., Crabb, John W.
Formato:	Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690477/ https://www.ncbi.nlm.nih.gov/pubmed/19202148 http://dx.doi.org/10.1074/mcp.M800453-MCP200

Ejemplares similares

Genetic analysis of complement factor H related 5, CFHR5, in patients with age-related macular degeneration
por: Narendra, Umadevi, et al.
Publicado: (2009)

Quantitative Proteomics: Comparison of the Macular Bruch Membrane/Choroid Complex from Age-related Macular Degeneration and Normal Eyes
por: Yuan, Xianglin, et al.
Publicado: (2010)

Plasma Protein Pentosidine and Carboxymethyllysine, Biomarkers for Age-related Macular Degeneration
por: Ni, Jiaqian, et al.
Publicado: (2009)

Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration
por: Kopplin, Laura J, et al.
Publicado: (2010)

Photoreceptor Compartment-Specific TULP1 Interactomes
por: Ebke, Lindsey A., et al.
Publicado: (2021)

Tear film proteome in age-related macular degeneration
por: Winiarczyk, Mateusz, et al.
Publicado: (2018)

Correction: ‘You’ve got dry macular degeneration, end of story’: a qualitative study into the experience of living with non-neovascular age-related macular degeneration
por: Taylor, Deanna J., et al.
Publicado: (2019)

Response to ‘Comment on: ‘You have got dry macular degeneration, end of story’: a qualitative study into the experience of living with non-neovascular age-related macular degeneration’
por: Taylor, Deanna J., et al.
Publicado: (2019)

Sequence alterations in RX in patients with microphthalmia, anophthalmia, and coloboma
por: London, Nikolas J.S., et al.
Publicado: (2009)

Recent advances of exosomes in age-related macular degeneration
por: Gu, Feng, et al.
Publicado: (2023)

The effect of non-neovascular age-related macular degeneration on face recognition performance
por: Taylor, Deanna J., et al.
Publicado: (2018)

Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration
por: Koss, Michael Janusz, et al.
Publicado: (2014)

Analysis of the Aqueous Humor Proteome in Patients With Age-Related Macular Degeneration
por: Rinsky, Batya, et al.
Publicado: (2021)

Genetic variation in complement regulators and susceptibility to age-related macular degeneration
por: Cipriani, Valentina, et al.
Publicado: (2012)

Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
por: Lynch, Anne M., et al.
Publicado: (2019)

Proteomics-based approach for differentiation of age-related macular degeneration sub-types
por: Sivagurunathan, Sivapriya, et al.
Publicado: (2021)

Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration
por: Senabouth, Anne, et al.
Publicado: (2022)

CETP/LPL/LIPC gene polymorphisms and susceptibility to age-related macular degeneration
por: Wang, Ya-Feng, et al.
Publicado: (2015)

Novel computer-based assessments of everyday visual function in people with age-related macular degeneration
por: Higgins, Bethany E., et al.
Publicado: (2020)

Bringing the age-related macular degeneration high-risk allele age-related maculopathy susceptibility 2 into focus with stem cell technology
por: Sun, Shuo, et al.
Publicado: (2017)

Macrophages and Macular Degeneration
por: Jager, Martine J.
Publicado: (2014)

Brolucizumab for macular degeneration
Publicado: (2020)

Proteomic Profiling of Aqueous Humor Exosomes from Age-related Macular Degeneration Patients
por: Tsai, Ching-Yao, et al.
Publicado: (2022)

Low-Density Lipoprotein Has an Enormous Capacity To Bind (E)-4-Hydroxynon-2-enal (HNE): Detection and Characterization of Lysyl and Histidyl Adducts Containing Multiple Molecules of HNE
por: Annangudi, Suresh P., et al.
Publicado: (2008)

The Association between LIPC rs493258 Polymorphism and the Susceptibility to Age-Related Macular Degeneration
por: Wang, Yafeng, et al.
Publicado: (2016)

Polygenic Risk Score Impact on Susceptibility to Age-Related Macular Degeneration in Polish Patients
por: Wąsowska, Anna, et al.
Publicado: (2022)

Geographic Atrophy: Confocal Scanning Laser Ophthalmoscopy, Histology, and Inflammation in the Region of Expanding Lesions
por: Bonilha, Vera L., et al.
Publicado: (2020)

Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
por: Upasani, Deepa, et al.
Publicado: (2021)

Systemic Blood Proteome Patterns Reflect Disease Phenotypes in Neovascular Age-Related Macular Degeneration
por: Künzel, Steffen E., et al.
Publicado: (2023)

Evidence of complement dysregulation in outer retina of Stargardt disease donor eyes
por: Hu, Jane, et al.
Publicado: (2020)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Age-related macular degeneration
por: Mathenge, Wanjiku
Publicado: (2014)

Advances in the management of macular degeneration
por: Singer, Michael
Publicado: (2014)

How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review
por: Taylor, Deanna J, et al.
Publicado: (2016)

Polymorphisms in PEDF linked with the susceptibility to age-related macular degeneration: A case–control study
por: Hao, Xiaolin, et al.
Publicado: (2018)

Are Current Methods of Measuring Dark Adaptation Effective in Detecting the Onset and Progression of Age-Related Macular Degeneration? A Systematic Literature Review
por: Higgins, Bethany E., et al.
Publicado: (2021)

Brolucizumab for persistent macular fluid in neovascular age-related macular degeneration after prior anti-VEGF treatments
por: Hussain, Rehan M., et al.
Publicado: (2021)

LAMELLAR MACULAR HOLES IN THE PRESENCE OF AGE-RELATED MACULAR DEGENERATION
por: Francone, Anibal, et al.
Publicado: (2020)

Recent Advances in Age-Related Macular Degeneration Therapies
por: Fabre, Marie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mf3ssslg5tu52k70n1j4ej13ku